AptaBio Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.6%.

Top 14 shareholders own 35.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.2%	Jin Soo	5,152,282	₩34.0b	0%	no data
9.28%	Hwan Sung	2,494,208	₩16.4b	0%	no data
3.29%	Moorim-Omega No.1 Investment Association	883,977	₩5.8b	0%	no data
2.87%	T.S. Investment Corporation	772,096	₩5.1b	175%	4.67%
0.89%	Ho-sang Moon	240,000	₩1.6b	0%	no data
0.25%	Aptabio Therapeutics Inc.Employee Stock Ownership Association	66,385	₩437.5m	0%	no data
0.074%	Midas Asset Management	20,000	₩131.8m	0%	0.01%
0.064%	Ji-gwon Moon	17,237	₩113.6m	0%	no data
0.05%	State Street Global Advisors, Inc.	13,345	₩87.9m	3.57%	no data
0.026%	Dimensional Fund Advisors LP	6,987	₩46.0m	0%	no data
0.0037%	Junhee Jung	1,000	₩6.6m	0%	no data
0.001%	Samsung Asset Management Company, Ltd.	279	₩1.8m	0%	no data
0.00064%	Mirae Asset Global Investments Co., Ltd.	171	₩1.1m	0%	no data
0.00042%	NH-Amundi Asset Management	112	₩744.0k	0%	no data